Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research Inc is a specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units, the Topical Products and Technology (TPT) Group and the Immunology Group.
Price: $4.67 | Change: +$0.02 | %Change: +0.43%
Volume: 112,347 | Day High/Low: 4.73/4.60 | 52 Week High/Low: 10.36/2.50
View modes: 
0 stars

RE:RE:RE:RE:Good Day on Solid Volume

...or a repeat of last summers 'unfortunate' conditions?? How do they insure against that if FDA won't accept chamber studies?  rate and reply
0 stars

RE:RE:RE:Good Day on Solid Volume

I think we have to realize that the past is not necessarily a reflextion of the future. Situations change, experience is gained and the timing is right. I cant say that I am a fan of management, but...read more
0 stars

RE:RE:Good Day on Solid Volume

I do not dispute the value of exposure chambers. But, they are mainly conducted for proof of concept and dosing information. WF10 already has/had its proof of concept with the 2010 trial. In...read more
0 stars

RE:Good Day on Solid Volume

I agree that Nuvo is a steal at this pirce level. Too much negativity? There is only one reason the stock is a steal and that is that mangement has decided to redo the WF10 Phase II trial. I guess...read more
0 stars

RE:RE:Good Day on Solid Volume

Although the shares barely moved into the green I do feel we have made the turned the corner,,,,,high volume  7 000 000  plus shares traded hands today.....  rate and reply
5 stars

RE:Good Day on Solid Volume

Yes it was a waste of at least a year bringing WF10 to market. Just google allergy testing and see the many articles AND advise from the FDA about allergy chambers . Shame on Nuvo for not being...read more
3 stars

Good Day on Solid Volume

Nuvo remains a virtual steal at these prices. Seeking Alpha sorts that out for us. Too much negative commentary has stymied the rise in share price. WF10 is emerging from that negativity unscathed...read more
5 stars

How much are we paying Bloom ???

RE: Nuvo Research Inc. Press Release - Updates Company Strategy   Nuvo Research 7:22 PM ...read more
0 stars

RE:RE:AGM

Thanks, sounds interesting. Probably not worth the airfare but looking forward to hearing about it.   We have the strength and organization and no doubt prepared representation to support and get...read more
3 stars

RE:April 18/15....New Seeking Alpha report on Nuvo..BUY

Very significant statement from SA about the 2014 WF10 trials... "Obviously the first indication that something was wrong should have been they couldn't find anyone with allergies. " And...read more
3 stars

Ready for a major breakout

A renewal of vigor is evident here. Horizons have become clearer and we are on the cusp of  significant news. WF10 is fully rehabilitated from what was abnormal and non representative trials in 2014...read more
0 stars

RE:AGM

I went last year.  Yes prepared statements followed by a presentation.  All fixed until the Q&A.  There are always a few irate investors who bash management and the board, a bunch that tell the...read more
0 stars

AGM

What exactly takes place at these AGMs? Is it more prepared statements, smoke and mirrors and straightforward voting or are specified topics discussed in detail followed by open q/a?  rate and reply
0 stars

RE:OXEFERIN ----Whats the hold up JL !!

The German plant is manufacturing Oxoferin for Ranbaxy in Asia and I presume also for S America and Europe ( ? ). As an immune drug and a derivative of Wf10, it might be more appropriately included...read more
5 stars

RE:April 18/15....New Seeking Alpha report on Nuvo..BUY

Its a pretty good summary of our recent and extant status. It puts to bed any further speculation about the efficacy of WF10 and how the 2014 trials were corrupted by non-conforming field conditions....read more
5 stars

April 18/15....New Seeking Alpha report on Nuvo..BUY

It Is Time To Buy Nuvo Research 0 comments Apr 18, 2015 11:40 PM | about stocks: NRIFF Summary WF10 has the potential to capture 10-15% of the U.S. refractory allergic...read more
0 stars

RE:RE:OXEFERIN ----Whats the hold up JL !!

Oxoferin has a positive impact on wound healing leading to contraction, closure and faster healing of wounds. Chronic, hard-to-heal wounds are a serious problem with an increasing incidence, according...read more
0 stars

RE:OXEFERIN ----Whats the hold up JL !!

Oxeferin is nothing other than a very diluted form of WF10. It is not regarded as antibiotic. The main reason for its use for dressing of wounds is not its bacterial activity but its immunomodulating...read more
0 stars

RE:RE:For the WF10 Doubters...PAR were Significant in 2014

Remember though .. this is NRI management your talking about ,,, if there is a way to Eff it up .. they will  rate and reply
0 stars

OXEFERIN ----Whats the hold up JL !!

Any reason why Nuvo did not attempt to get OXEFERIN approved in the states ?? The market for treating bed sore patients in nursing homes is HUGE !!  Can this question be raised at the meeting in May ?...read more